Related Experiment Video
Updated: May 25, 2026

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells
Published on: May 22, 2014
NLRP3 inflammasome is a target for development of broad-spectrum anti-infective drugs
James D Thacker1, Brian J Balin, Denah M Appelt
1Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA. jim_thacker@therimunex.com
Abstract:
We describe the molecular mode of action and pharmacodynamics of a new molecular entity (NME) that induces the NLRP3 inflammasome-mediated innate immune response. This innate response reduces the pathogen load in an experimentally induced methicillin-resistant Staphylococcos aureus infection, enhances survival in an experimentally induced Gram-negative bacteremia, and overrides the escape mechanism of an obligate intracellular pathogen, viz. Chlamydia pneumoniae. Furthermore, the NME is more effective than standard-of-care antibiotic therapy in a clinically established multifactorial bacterial infection. Analysis of transcriptional regulation of inflammasome signaling genes and innate/adaptive immune genes revealed consistent and significant host changes responsible for the improved outcomes in these infections. These studies pave the way for the development of first-in-class drugs that enhance inflammasome-mediated pathogen clearance and identify the NLRP3 inflammasome as a drug target to address the global problem of emerging new infectious diseases and the reemergence of old diseases in an antibiotic-resistant form.
Insights
A novel molecular entity activates the NLRP3 inflammasome, enhancing the innate immune response to combat bacterial infections, including antibiotic-resistant strains, and improving survival rates.
Area of Science:
- Immunology
- Microbiology
- Pharmacology
Background:
- The rise of antibiotic-resistant bacteria and emerging infectious diseases necessitates novel therapeutic strategies.
- The NLRP3 inflammasome is a key component of the innate immune system involved in pathogen recognition and clearance.
Purpose of the Study:
- To elucidate the molecular mechanism of a new molecular entity (NME) that activates the NLRP3 inflammasome.
- To evaluate the efficacy of the NME in preclinical models of bacterial infections.
Main Methods:
- Investigated the NME's molecular mode of action and pharmacodynamics.
- Assessed the NME's impact on experimentally induced infections (MRSA, Gram-negative bacteremia, Chlamydia pneumoniae) and a multifactorial bacterial infection.
- Analyzed transcriptional changes in inflammasome signaling and immune genes.
Main Results:
- The NME effectively reduces pathogen load and enhances survival in various bacterial infection models.
- It demonstrates superior efficacy compared to standard antibiotic therapy in a complex infection model.
- Transcriptional analysis revealed significant host immune gene modulation.
Conclusions:
- The NME potentiates the NLRP3 inflammasome-mediated innate immune response for pathogen clearance.
- This NME represents a promising therapeutic candidate for treating antibiotic-resistant and emerging infectious diseases.
- Targeting the NLRP3 inflammasome offers a novel strategy against challenging bacterial infections.
More Related Videos
06:52Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
Published on: May 21, 2018
08:14Detection of Intracellular Gene Expression in Live Cells of Murine, Human and Porcine Origin Using Fluorescence-labeled Nanoparticles
Published on: November 13, 2015
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Regulation of the Unfolded Protein Response